Eisai CEO retires

Share this article:

Eisai's president and CEO Lonnel Coats is retiring. The company announced Monday that Coats will leave the company in June, but will hand off his titles April 1, the first day of the company's new fiscal year.

Yuji Matsue will be the new chairman and CEO and will oversee “the strategic direction of the Americas Region.” Shaji Procida, the new president and COO as of April 1, will “have full operating responsibility for the US Business.”

The new executive lineup accompanies an organizational change that also goes into effect April 1. The company noted in its third-quarter earnings for FY 2014 that the pharmaceutical businesses will be designated as follows in FY2015: Japan (prescription drugs, generic drugs and diagnostics), Americas (North, Central and South), Asia (China, South Korea, Taiwan, India and ASEAN), EMEA (Europe, Middle East, Africa and Oceania) and Consumer Healthcare Businesses.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters